期刊文献+

HBV感染小鼠模型的研究进展 被引量:2

Research advances in mouse models of hepatitis B virus infection
下载PDF
导出
摘要 HBV由于其较强的种属特异性,目前尚缺乏理想的实验动物模型来阐明其具体的发病机制。目前有关HBV感染模型的研究大多集中在小鼠方面,并已取得了很大进展。综述了HBV转基因小鼠、HBV转染小鼠和人鼠嵌合肝脏HBV小鼠等模型的优缺点,提出合理使用这些模型有助于更好地阐明HBV的致病机制。 Hepatitis B virus (HBV) is a great threat to human health, but due to its strong species specificity, there are still no ideal animal models at present to clarify the pathogenesis of HBV infection. At present, the research on HBV infection models mainly concentrates on mice, and great progress has been achieved/made. This review focuses on the advantages and disadvantages of HBV transgenic mouse mod- el, HBV - transfected mouse model, and human - mouse chimeric liver HBV mouse model, and suggests that rational application of these models helps to clarify the pathogenesis of HBV.
出处 《临床肝胆病杂志》 CAS 2016年第1期165-168,共4页 Journal of Clinical Hepatology
基金 国家自然科学基金(31172167)
关键词 肝炎病毒 乙型 模型 动物 小鼠 转基因 综述 hepatitis B virus models, animal mice, transgenic review
  • 相关文献

参考文献3

二级参考文献74

  • 1Chisari FV,Ferrari C. Hepatitis B virus immunopathogen- esis. Annu Rev Immunol 1995; 13: 29-60. 被引量:1
  • 2Sidenius N,Sier CF,Ullum H,Pedersen BK,Lepri AC,Blasi F,Eugen-Olsen J. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus in- fection. Blood 2000; 96: 4091-4095. 被引量:1
  • 3Mondino A,Blasi F. uPA and uPAR in fibrinolysis,immu- nity and pathology. Trends Immunol 2004; 25: 450-455. 被引量:1
  • 4Chapman HA. Plasminogen activators,integrins,and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9: 714-724. 被引量:1
  • 5Ossowski L,Clunie G,Masucci MT,Blasi F. In vivo para- crine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol 1991; 115: 1107-1112. 被引量:1
  • 6Lund AH,Turner G,Trubetskoy A,Verhoeven E,Wientjens E,Hulsman D,Russell R,DePinho RA,Lenz J,van Lohuizen M. Genome-wide retroviral insertional tagging of genes in- volved in cancer in Cdkn2a-deficient mice. Nat Genet 2002; 32: 160-165. 被引量:1
  • 7Stephens RW,Nielsen HJ,Christensen IJ,Thorlacius-Ussing O,S?rensen S,Dan? K,Brünner N. Plasma urokinase recep- tor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 1999; 91: 869-874. 被引量:1
  • 8Mustjoki S,Sidenius N,Sier CF,Blasi F,Elonen E,Alitalo R,Vaheri A. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. Cancer Res 2000; 60: 7126-7132. 被引量:1
  • 9Dobrovolsky VN,Heflich RH. On the use of the T-REx tetra- cycline-inducible gene expression system in vivo. Biotechnol Bioeng 2007; 98: 719-723. 被引量:1
  • 10Stieger K,Belbellaa B,Le Guiner C,Moullier P,Rolling F. In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev 2009; 61: 527-541. 被引量:1

共引文献667

同被引文献14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部